Related Experiment Video
Updated: Jul 12, 2026
03:59
Therapeutic Massage for Psychological Well-being in Geriatric Oncology
Published on: May 22, 2026
How do we include geriatricians in geriatric oncology? The geriatrician's perspective
Celia Gabriela Hernández Favela1, Carolina Gómez Moreno2, Wee Kheng Soo3
1Department of Geriatric Medicine, University of Toronto, Toronto, Canada; Geriatric Service, Sunnybrook Health Sciences Centre, Toronto, Canada.
Journal of Geriatric Oncology
|July 9, 2026
Summary
Integrating geriatricians into cancer care improves outcomes for older adults. Strategies address workforce shortages and implementation barriers, enhancing quality of life and survival.
Area of Science:
- Geriatric Medicine
- Oncology
- Cancer Care
Background:
- Older adults comprise the majority of cancer patients.
- Geriatric expertise is currently underrepresented in oncology.
- This gap impacts care quality and patient outcomes.
Purpose of the Study:
- To review practical strategies for integrating geriatricians across the cancer care continuum.
- To explore models of collaboration and innovative solutions for geriatrician shortages.
- To highlight the benefits of comprehensive geriatric assessment in older cancer patients.
Main Methods:
- Literature review of existing evidence and emerging strategies.
- Analysis of interdisciplinary collaboration models.
- Discussion of implementation barriers and potential solutions.
Main Results:
- Comprehensive geriatric assessment improves treatment tolerance, quality of life, and survival.
- Implementation barriers include workforce limitations, time constraints, and lack of support.
- Emerging strategies include task-shifting, telehealth, and education.
Conclusions:
- Integrating geriatricians into multidisciplinary oncology teams is crucial for equitable, personalized cancer care.
- Structured collaboration, institutional support, and policy initiatives are needed.
- Geriatric oncology is essential for optimizing care for aging populations with cancer.
Related Concept Videos
01:15Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...